Equities analysts forecast that Aramark (NYSE:ARMK) will post $3.87 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Eleven analysts have provided estimates for Aramark’s earnings, with estimates ranging from $3.83 billion to $3.91 billion. Aramark posted sales of $3.74 billion during the same quarter last year, which would indicate a positive year over year growth rate of 3.5%. The company is expected to report its next quarterly earnings report on Tuesday, February 6th.

According to Zacks, analysts expect that Aramark will report full year sales of $3.87 billion for the current year, with estimates ranging from $15.01 billion to $15.65 billion. For the next fiscal year, analysts anticipate that the business will post sales of $15.67 billion per share, with estimates ranging from $15.34 billion to $16.46 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Aramark.

Aramark (NYSE:ARMK) last issued its quarterly earnings results on Tuesday, November 14th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.02. The company had revenue of $3.65 billion for the quarter, compared to analyst estimates of $3.70 billion. Aramark had a net margin of 2.56% and a return on equity of 19.29%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 earnings per share.

A number of brokerages recently issued reports on ARMK. Zacks Investment Research raised Aramark from a “sell” rating to a “hold” rating in a report on Wednesday, November 22nd. Royal Bank of Canada upped their price target on Aramark from $44.00 to $47.00 and gave the company an “outperform” rating in a report on Tuesday, October 17th. Nomura lowered their price target on Aramark from $47.00 to $45.00 and set a “buy” rating for the company in a report on Wednesday, November 15th. BidaskClub raised Aramark from a “sell” rating to a “hold” rating in a report on Saturday, September 23rd. Finally, Barclays reaffirmed a “hold” rating and issued a $45.00 price target on shares of Aramark in a report on Thursday, October 19th. Three analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Aramark has an average rating of “Buy” and an average price target of $44.83.

In related news, Director Sanjeev K. Mehra purchased 19,640 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was acquired at an average price of $40.75 per share, for a total transaction of $800,330.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.90% of the stock is currently owned by corporate insiders.

A number of large investors have recently added to or reduced their stakes in the business. Pitcairn Co. raised its position in Aramark by 3.2% in the second quarter. Pitcairn Co. now owns 8,330 shares of the company’s stock worth $341,000 after acquiring an additional 255 shares in the last quarter. Pacer Advisors Inc. increased its position in shares of Aramark by 8.3% in the second quarter. Pacer Advisors Inc. now owns 4,871 shares of the company’s stock valued at $200,000 after buying an additional 374 shares in the last quarter. Howard Hughes Medical Institute increased its position in shares of Aramark by 0.7% in the second quarter. Howard Hughes Medical Institute now owns 57,423 shares of the company’s stock valued at $2,353,000 after buying an additional 382 shares in the last quarter. Utah Retirement Systems increased its position in shares of Aramark by 0.9% in the second quarter. Utah Retirement Systems now owns 44,500 shares of the company’s stock valued at $1,824,000 after buying an additional 400 shares in the last quarter. Finally, Toronto Dominion Bank increased its position in shares of Aramark by 19.0% in the second quarter. Toronto Dominion Bank now owns 3,027 shares of the company’s stock valued at $124,000 after buying an additional 483 shares in the last quarter. Hedge funds and other institutional investors own 95.68% of the company’s stock.

Shares of Aramark (ARMK) opened at $42.27 on Wednesday. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.86 and a current ratio of 1.12. Aramark has a one year low of $32.87 and a one year high of $44.12. The firm has a market cap of $10,517.07, a P/E ratio of 24.25, a P/E/G ratio of 1.82 and a beta of 0.47.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 7th. Stockholders of record on Monday, November 27th were issued a $0.105 dividend. This is an increase from Aramark’s previous quarterly dividend of $0.10. This represents a $0.42 annualized dividend and a dividend yield of 0.99%. The ex-dividend date of this dividend was Friday, November 24th. Aramark’s dividend payout ratio is presently 28.19%.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/13/aramark-armk-expected-to-post-quarterly-sales-of-3-87-billion.html.

About Aramark

Aramark is a global provider of food, facilities and uniform services to education, healthcare, business and industry, and sports, leisure and corrections clients. The Company operates through three segments: Food and Support Services North America (FSS North America), Food and Support Services International (FSS International), and Uniform and Career Apparel (Uniform).

Get a free copy of the Zacks research report on Aramark (ARMK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aramark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aramark and related companies with MarketBeat.com's FREE daily email newsletter.